Last reviewed · How we verify
NCT04356092
2D Perfusion DSA for the Quantification of Infrapopliteal Angioplasty
NA trial testing 2D perfusion digital subtraction angiography of the foot. in Ischemia Limb in 7 participants. Completed in 14 July 2019.
14 July 2019
Quick facts
| Lead sponsor | Attikon Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 7 |
| Start date | 2 May 2017 |
| Primary completion | 14 July 2019 |
| Estimated completion | 14 July 2019 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- 2D perfusion digital subtraction angiography of the foot.
Conditions studied
- Ischemia Limb — all drugs for Ischemia Limb →
Sponsor
Attikon Hospital
Who can join
Adults 18 to 90, any sex, with Ischemia Limb. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A custom-made, 2D-perfusion digital subtraction angiography (PDSA) algorithm has been designed and implemented towards foot perfusion quantification following endovascular treatment of critical limb ischemia (CLI), in order to assist intra-procedural decision-making and enhance clinical outcomes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
2D perfusion DSA with an open-source, semi-automated, color-coded software for the quantification of foot perfusion following infrapopliteal angioplasty: a feasibility study.
Kagadis GC, Tsantis S, Gatos I, Spiliopoulos S, et al · · 2020 · cited 6× · PMID 32875390 · DOI 10.1186/s41747-020-00176-z
Verify or expand the search:
- PubMed search for NCT04356092
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Attikon Hospital trials
Trials by the same sponsor.
- NCT07425457 — Cryoneurolysis Prior to Total Knee Arthroplasty (CRYO-TKA Trial) · NA · recruiting
- NCT06646107 — Adherence to Mediterranean Diet in Type 1 Diabetes Initiating Minimed 780G: Glucose Metrics vs Insulin Metrics, is There · recruiting
- NCT06810700 — The Association Between Time in Range With Markers of Endothelial and Cardiovascular Function · not yet recruiting
- NCT06978387 — The Association Between Glycemic Metrics and Cardiovascular Markers in Patients With Type 1 Diabetes. · active not recruiting
- NCT06749613 — Digestive Enzyme Formulation Intervention in IBS Patients Who Previously Clinically Responded to Mediterranean LFD · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04356092 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Attikon Hospital
- Last refreshed: 22 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04356092.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing